- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/433 - Thiadiazoles
Patent holdings for IPC class A61K 31/433
Total number of patents in this class: 1666
10-year publication summary
|
122
|
118
|
149
|
116
|
98
|
116
|
105
|
107
|
98
|
72
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4875 |
35 |
| Novartis AG | 10883 |
23 |
| Merck Sharp & Dohme LLC | 3743 |
17 |
| The Regents of the University of California | 19839 |
16 |
| Takeda Pharmaceutical Company Limited | 2708 |
16 |
| Universite de Montreal | 343 |
15 |
| Board of Regents, The University of Texas System | 5754 |
14 |
| Abbvie Inc. | 1803 |
13 |
| Array BioPharma Inc. | 505 |
13 |
| Betagenon AB | 24 |
13 |
| Calithera Biosciences, Inc. | 45 |
13 |
| Proteostasis Therapeutics, Inc. | 70 |
12 |
| Daiichi Sankyo Company, Limited | 1855 |
11 |
| Ovid Therapeutics Inc | 155 |
11 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
11 |
| Calico Life Sciences LLC | 96 |
11 |
| Hoffmann-La Roche Inc. | 3387 |
10 |
| Boehringer Ingelheim International GmbH | 4698 |
10 |
| The Board of Trustees of the Leland Stanford Junior University | 6380 |
10 |
| Cardioxyl Pharmaceuticals, Inc. | 49 |
10 |
| Other owners | 1382 |